Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1763625
Name of medicinal product: CASPOFUNGIN SANDOZ
Active substances:
Estonian, English, Latin
ATC code: J02AX04
Dosage form: powder for concentrate for solution for infusion
Route of administration: intravenous use
Strengh: 70mg
Amount in package: 10ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: - Treatment of invasive candidiasis in adult or paediatric patients. - Treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin B lipid formulations of amphotericin B and/or itraconazole. Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy. - Empirical therapy for presumed fungal infections (such as Candida or Aspergillus) in febrile, neutropenic adult or paediatric patients.
Safety features: Yes
Summary of product characteristics (SPC):  (last updated March 31, 2021)
Package information leaflet (PIL): EST  (last updated May 25, 2020)
Labelling:  (last updated October 2, 2018)
Last imported to Estonia: June 12, 2024
Marketing authorization holder: Sandoz Pharmaceuticals d.d. 
Marketing authorization number: 972318 
Marketing authorization issued on: October 2, 2018 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Description Additional condition
Hambaarstil on õigus välja kirjutada
Entry/Changing date: June 6, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere